Tandem Diabetes Care, Inc.has introduced the Tandem Choice technology access program. This initiative offers eligible customers of the t:slim X2 Insulin Pump the chance to acquire ownership of the Tandem Mobi System for $199. The Tandem Mobi System has recently gained clearance from the U.S. FDA to be incorporated into automated insulin delivery systems. It is expected to be launched in a limited capacity later this year, with full availability projected for early 2024.
About the Program
The Tandem Choice Program, available for a limited time, offers the Tandem Mobi System for $199 to customers who purchase a t:slim X2 between July 1, 2023, and December 31, 2023. Those with a t:slim X2 purchased before July 1, 2023, and more than 12 months remaining on their warranty can also join for the original price of $999. Eligible customers can participate until December 31, 2024, and a switch from t:slim X2 to Tandem Mobi is possible upon participation.
The new Tandem Mobi, much smaller than the t:slim X2, can be controlled through an iOS mobile app and offers diverse wearability options. It features an on-pump button for insulin delivery and is compatible with existing Tandem infusion sets.
For further details, visit the official website: Tandem Choice Program Details.
This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or healthcare provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit diabeteseducator.org.
ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.